Samsung Biologics has appointed Seungho Yu, the CFO, as an internal director, and Ho-seung Lee, the former Presidential Chief of Staff, as an external director. The company expects Yu to provide professional insights into the company’s financial structure analysis and strategy formulation. Lee, with his public service experience, will supervise the company’s management activities and internal control functions to enhance corporate management transparency. The limit of director compensation was also increased from 15 billion won last year to 20 billion won this year.
Original Article: Read More
Auto-posted at: 2025-03-14 10:55:59